At 36 weeks, weight loss ranged from 9.4% to 14.7% in GLP-1 patients, compared with 2.3% in the placebo group
Tell your healthcare provider if you have changes in vision during treatment with Wegovy increased heart rate
Synergy with GLP-1 medications: Enhances drug efficacy by improving gut hormone synergy, potentially allowing lower doses or smoother transitions during weaning
Inborn errors Congenital defects involve enzyme deficiencies in the carnitine transport or metabolic pathways, such as CPT II deficiency, which affects the function of the carnitine transporter CPT II and leads to impaired fatty acid -oxidation, and CACT deficiency, which affects the function of the carnitine transporter CACT and results in carnitine shuttle dysfunction
Kitano Y, Hashimoto S, Matsumoto H, Yamochi T, Yamanaka M, Nakaoka Y, Fukuda A, Inoue M, Ikeda T, Morimoto Y (2018) Oral administration of l-carnitine improves the clinical outcome of fertility in patients with IVF treatment
Bruciore di stomaco